CClinicalTrials.gg
Active, not recruitingNCT06981871Updated Sep 18, 2026

Prevalence of Lower and Upper Incisor Periodontal Phenotypes and Risk Indicators.

An observational study in Gingiva and Phenotype, sponsored by Centre Hospitalier Universitaire de Nice. Active, not recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-18.

Sponsored by Centre Hospitalier Universitaire de Nice · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
245
Ages
18 Years and older
Sex
All
01

Study summary

The determination of the periodontal phenotype is an essential part of the periodontal diagnostic process, which must guide not only treatment but also prognosis (Kim et al. 2020).

This determination is based on the clinical assessment of 3 individual variables: gingival height/thickness and alveolar bone cortical thickness. Although these anatomical characteristics are genetically determined, they are also influenced by numerous acquired, endogenous or exogenous factors that can act at a general and/or local level. The periodontal phenotype is therefore specific to an individual and its 3 components vary over time according to the dental sectors and sites of each individual. For example, the morphology of this phenotype varies according to whether the gingiva is thick or thin, high or reduced, and the bone cortex is thick or thin, with all possible combinations. Clinicians need to know the distribution of these different types of phenotypes, particularly in the aesthetic areas they are concerned with, in order to better identify the most fragile ones in the face of the multiple daily stresses to which the periodontium may be subjected: muscular force, dental plaque, oral hygiene manoeuvres, parafunctionality, dental procedures....

However, studies on the prevalence of the periodontal phenotype are limited and mainly concern Asian, Indian and American populations, with very few studies on European populations. Main objective: To assess the prevalence of periodontal phenotypes in the upper and lower incisors of French subjects, according to tooth type and at the individual level. Secondary objective: Identification of potential risk indicators in relation to the type of periodontal phenotype."

02

Conditions studied

  • Gingiva
  • Phenotype
03

In context

Lead sponsor

Centre Hospitalier Universitaire de Nice is the lead sponsor of 709 studies on the registry; 176 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

Dental students at the university hospitals of Nice and Nancy (France)

Inclusion criteria

  • Age (18 years old or older),
  • Dental student on the university hospitals of Nice and Nancy.
  • Social security affiliate.
  • Systemically healthy.
  • Healthy and intact periodontium.
  • Informed consent.

Exclusion criteria

Exclusion Criteria:

  • Pregnancy.
  • Under any regular medical treatment.
  • Active periodontal disease.
  • Enduring orthodontic treatment.
  • Periodontal surgery in the mandibulary anterior region.
  • Non consent patient.
  • Patient under judgment trials.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
245 participants (estimated)
Patient registry
No

Interventions

  • OtherEvaluation of the gingival phenotype of the incisors in the upper and lower jaws

    Assessment of gingival thickness (Kan et al 2015) and keratinised tissue height of the incisors with UNC-15 peridontal probe (Hu-Freidy, USA) and clinical photography.

06

What researchers measure

Primary outcomes

  1. Prevalence of gingival phenotypes (gingival thickness )

    Assessment of gingival thickness

    Time frame: At the inclusion

  2. Prevalence of gingival phenotypes (keratinised tissue height)

    Evaluation of keratinised tissue height of the lower and upper incisors with UNC-15 peridontal probe (mm) and clinical photography.

    Time frame: At the inclusion

  3. Prevalence of gingival phenotypes (Photography)

    Description of the gingiva

    Time frame: At the inclusion

Secondary outcomes

  1. Associated risk indicators for thin gingival phenotype ( Clinical description)

    Global description clinical multiples evaluations ( Age, gender, smoking habit, orthodontic background, oral hygiene habit, oral ventilation, dysfunction, facial typology, chin shape, visibility of vascularisation and root convexity through the gum, gingival récession (Cairo), freinal insertion and skin type).

    Time frame: At the inclusion

  2. Associated risk indicators for thin gingival phenotype ( orthodontic and facial characteristics )

    Global description clinical evaluation based on photographs.

    Time frame: At the inclusion

07

Study locations

1 site
  • CHU NICE
    Nice, Alpes Maritimes 06000, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06981871
Lead sponsor
Centre Hospitalier Universitaire de Nice
Responsible party
Sponsor
First posted
May 21, 2025
Start date
Jun 1, 2025
Primary completion
Nov 1, 2026 (estimated)
Completion
Nov 1, 2026 (estimated)
Last update
Sep 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion